Biodistribution and Radiation Dosimetry of the Enterobacteriaceae-Specific Imaging Probe [18F]Fluorodeoxysorbitol Determined by PET/CT in Healthy Human Volunteers

Molecular Imaging and Biology

Volumn 18, Issue 5, 2016, Pages 782-787

  Zhu, Wenjia ^a   Yao, Shaobo ^a   Xing, Haiqun ^a   Zhang, Hui ^b   Tai, Yuan chuan ^c   Zhang, Yingqiang ^a   Liu, Yimin ^a   Ma, Yanru ^a   Wu, Chenxi ^a   Wang, Hongkai ^d   Li, Zibo ^e   Wu, Zhanhong ^e   Zhu, Zhaohui ^a   Li, Fang ^a   Huo, Li ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b TSINGHUA UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Biodistribution; Enterobacteriaceae; PET; Radiation dosimetry; 18F FDS

Indexed keywords

FLUORODEOXYSORBITOL F 18; TRACER; UNCLASSIFIED DRUG; 2-DEOXY-2-FLUOROSORBITOL; FLUORINE; MOLECULAR PROBE; SORBITOL;

ADULT; ARTICLE; BACKACHE; BACTERIAL STRAIN; BLADDER; BLOOD; BRAIN SCINTISCANNING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG SAFETY; EFFECTIVE DOSE (RADIATION); ENTEROBACTERIACEAE; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; HUMAN EXPERIMENT; INTESTINE; MALE; MIDDLE AGED; MUSCLE SPASM; NORMAL HUMAN; PET-CT SCANNER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; SHOULDER DISEASE; TARGET ORGAN; URINARY TRACT; WHOLE BODY PET; ANALOGS AND DERIVATIVES; ANTIBODY SPECIFICITY; CHEMISTRY; CLINICAL TRIAL; IMAGE PROCESSING; METABOLISM; MOLECULAR PROBE; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; RADIATION RESPONSE; RADIOMETRY; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

ADULT; ENTEROBACTERIACEAE; FEMALE; FLUORINE RADIOISOTOPES; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MOLECULAR PROBES; ORGAN SPECIFICITY; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOMETRY; SORBITOL; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84961644386     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-016-0946-9     Document Type: Article

References (24)

1. Wang X, Murthy N (2014) Bacterial imaging comes of age. Sci Transl Med 6:259fs43–259fs43
2. Littenberg RL, Taketa RM, Alazraki NP et al (1973) Gallium-67 for localization of septic lesions. Ann Intern Med 79:403–406
3. Erba PA, Martina S, Umberto C et al (2013) Radiolabeled wbc scintigraphy in the diagnostic workup of patients with suspected device-related infections. Jacc Cardiovasc Imaging 6:1075–1086
4. 99mTc radiolabeled monoclonal antibodies for diagnosis. Radiology 245:732–741
5. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation. J Nucl Med 48:337–343
6. 18F-FDG PET or PET/CT in the detection of fever of unknown origin. Eur J Radiol 81:3524–9
7. 99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with staphylococcus aureus. J Nucl Med 45:321–326
8. 68Ga-Ferrioxamine E for Aspergillus infection imaging: uptake specificity in various microorganisms. Mol Imaging Biol 16:102–108
9. 123I-labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice. J Nucl Med 45:1209–1216
10. 124I]FIAU-PET/CT. PLoS ONE 2:e1007
11. Gowrishankar G, Namavari M, Jouannot EB et al (2014) Investigation of 6-[18F]-Fluoromaltose as a novel PET tracer for imaging bacterial infection. Plos One 9:e107951–e107951
12. Xinghai N, Wonewoo S, Seungjun L et al (2014) PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed 53:14096–14101
13. 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med 6:259ra146–259ra146
14. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. National Cancer Institute. Published on June 14, 2010. www.ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40
15. Tang GH, Tang XL, Wang MF et al (2006) High efficient automated synthesis of 2-[18F] fluoro-2-deoxy-D-glucose. Nucl Technol 29:531–536
16. 18F-FDS and its potential application in molecular imaging. Mol Imaging Biol 10:92–98
17. Wolf I, Vetter M, Wegner I et al (2005) The medical imaging interaction toolkit. Med Image Anal 9:594–604
18. Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023–1027
19. International Commission on Radiological Protection (ICRP) (1994) Basic anatomical and physiological data for use in radiological protection: the skeleton. ICRP publication 70. Ann ICRP 25:66–67
20. 18F-FDS and first-in-human evaluation, Nucl Med Biol 43:206–14
21. International Commission on Radiological Protection (ICRP) (2015) Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP Publication 128. Ann ICRP 44:107–109
22. Radioactive drugs for certain research uses. Code of Federal Regulations. Title 21, Volume 5. Sec. 361.1. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr5361
23. Kaushik A, Jaimini A, Tripathi M et al (2015) Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol. Indian J Med Res 142:721–31
24. Divoli A, Chiavassa S, Ferrer L et al (2009) Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies. J Nucl Med 50:316–323